Summary |
|
||||||||
Variant origin |
|
||||||||
Variant description |
|
||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:15235In an intraspecific backcross BALB/cAnPt females x (BALB/cAnPt x DBA/2N)F1 males, where BALB/cAnPt is susceptible to plasmacytoma tumors and the F1 hybrid strain is resistant, 83 out of 773 progeny developed tumors suggesting a multiple trait inheritance. The initial 28 progeny tested for Pcts1 showed significant Chi square values with Chromosome 4 markers Ifa, Mtv13 and Nppa; the progeny also being homozygous susceptible BALB/cAnPt. Further analysis of 77 susceptible backcross progeny gave 9 recombinants between Pcts1 and Gt10 suggesting a distance within 11.6 +/- 3.6 cM between the two. Homozygosity for BALB/cAnPt-derived alleles is associated with sussceptibility to pristane-induced plasmacytomas. |
||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|